Enjoy complimentary customisation on priority with our Enterprise License!
The stem cell banking market size is estimated to grow by USD 8.23 billion at a CAGR of 11.65% between 2023 and 2027. The market growth is fueled by the escalating demand for personalized medicines, coupled with advancements in regenerative medicine. Personalized banking applications facilitate tailored treatments, aligning with individual patient characteristics and preferences. Stem cell-based research, especially in hematopoietic stem cell transplantations, holds promise for addressing neurodegenerative and cardiovascular conditions. Tissue banks and biobanks play a pivotal role in storing adult tissues and stem cells, both used and unused, for clinical applications. Cryogenically freezing enables the long-term preservation of stem cells for future therapies. Progress in regenerative medicine, including IPS cells, offers hope for conditions previously deemed untreatable. Despite initial costs, market research and growth analysis project a promising market forecast, emphasizing the importance of continued innovation and investment in personalized healthcare solutions..
For More Highlights About this Report, Download Free Sample in a Minute
This report extensively covers the market segmentation by product type (adult stem cells, umbilical cord blood stem cells, and embryonic stem cells), type (private and public), and geography (North America, APAC, Europe, South America, Middle East and Africa).
The market share growth by the adult stem cells segment will be significant during the forecast period. The Stem Cell Banking Market is driven by the self-renewing and in situ generation properties of stem cells, making them ideal for illness therapy. They are found in various tissues including the heart, brain, and kidney, offer benefits such as ease of harvesting, high acceptance in the human body, and effectiveness in tissue regeneration.
Get a glance at the market contribution of various segments Download the PDF Sample
The adult stem cells segment was valued at USD 4.08 billion in 2018. These cells rapidly migrate to sites of inflammation, triggering the immune system for better healing. Despite these advantages, limitations such as HLA compatibility hinder their adoption in procedures like bone marrow transplantations. The aging population and the prevalence of degenerative diseases like osteoarthritis, cardiovascular disease, Alzheimer's, and Parkinson's create a consumer base for stem cell preservation. Biotechnology specialists are developing novel technologies to rebuild damaged tissues, improving the quality of life for the elderly and those suffering from genetic illnesses like muscular dystrophy, cystic fibrosis, and Huntington's disease. Ethical issues surrounding the use of embryonic stem cells, which involve the destruction of embryos, continue to be a subject of ethical discussion. Non-controversial sources like adult stem cells from cord blood are gaining popularity. The healthcare industry invests in medical infrastructure, including cryogenic storage, to ensure the availability and accessibility of these valuable cells for various therapies. Awareness and understanding of the regenerative potential of stem cells are crucial for their widespread adoption. Hence, these factors will drive the growth of the global market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market in North America is driven by the self-renewing and in situ generation properties of stem cells, making them ideal for illness therapy and cardiovascular tissue repair. Blood diseases, such as genetic illnesses like muscular dystrophy, cystic fibrosis, and Huntington's disease, can be treated through stem cell replacement and repair. Novel technologies and the presence of biotechnology specialists have led to significant benefits in stem cell preservation for various degenerative diseases, including osteoarthritis, cardiovascular disease, neurological disorders like Alzheimer's and Parkinson's, and ageing population. The healthcare treatments and consumer base are expanding due to increasing awareness and the regenerative potential. Ethical issues surrounding the use of embryonic stem cells, which involve the destruction of embryos, have led to discussions on the use of non-controversial sources, such as adult stem cells from cord blood. The medical infrastructure supports the growth of this market through cryogenic storage solutions. Hence, such factors will drive the demand for stem-cell banking, thereby driving the regional market during the forecast period.
The market has witnessed significant growth in recent years due to the increasing demand for personalized medicine and therapeutic options for various chronic diseases, including Leukemia, Neurodegenerative conditions, and Cardiovascular conditions. Stem cells, such as those found in placental tissue, bone marrow, adipose tissue, and dental pulp, have immense potential in the field of medicine. Stem cell banking involves the collection, processing, and cryogenic freezing of these tiny cells for future use. Stem cell transplants have become a viable treatment mechanism for numerous conditions, and the ability to store and transfer these cells efficiently is crucial. Operational costs associated with stem cell banking can be high due to the complex process of collecting, processing, and storing these cells. However, the potential benefits far outweigh the costs, as these cells can provide life-saving treatments for individuals suffering from immune rejection or chronic diseases. Stem cell banks play a vital role in the advancement of stem cell research and personalized medicine, particularly for the aging population. As research continues to uncover new therapeutic options, the demand for stem cell banking services is expected to increase.
The surge in demand for tailored medications is the primary driver of market expansion. The Stem Cell Banking Market encompasses the storage and preservation of valuable human stem cells, including embryonic and induced pluripotent stem cells (iPSCs), as well as tissue-specific and somatic stem cells. These biological assets hold immense potential for regenerative medicine, particularly in addressing orthopaedic problems and autoimmune disorders. Stem cell therapies in medicine offer promising solutions for various diseases and disorders, such as leukemia, neurodegenerative conditions, and cardiovascular conditions. Sample analysis and processing are crucial steps in the banking process. These are derived from adult tissues, peripheral blood, and other sources are cryogenically frozen to maintain their viability and functionality.
Additionally, this advanced technology enables the prevention of immune rejection and ensures the availability of personalized biological insurance for future therapeutic applications. Government organizations, such as the National Institutes of Health (NIH) in the US, have significantly increased their investment in stem cell research, with approximately USD 1.6 billion allocated in 2019. The NIH currently focuses on iPSC technology to study disease mechanisms in age-related macular degeneration and other chronic diseases affecting the aging population. Stem cell banking plays a vital role in facilitating clinical trials for regenerative medicine, including cancer, diabetes, and other debilitating conditions. Hence, such factors will drive the growth of the market during the forecast period.
The increasing awareness regarding research and potential clinical applications for stem cells is the primary trend shaping market growth. The Stem Cell Banking Market encompasses the collection, processing, and cryogenic preservation of human stem cells, primarily derived from umbilical cord blood, but also including human embryonic cells, Induced Pluripotent Stem (IPS) cells, and somatic stem cells. These biological assets hold immense potential for regenerative medicine, offering novel approaches to address various diseases and disorders, such as orthopaedic problems, autoimmune conditions, and neurodegenerative diseases. Sample analysis and processing are crucial steps in stem cell banking, ensuring the viability and quality for future therapeutic applications.
Moreover, stem cell therapies have shown promise in treating a range of conditions, including leukemia, chronic diseases, and aging-related disorders like cardiovascular conditions. Regenerative medicine and personalized medicine are at the forefront of medicine's evolution, with these playing a pivotal role. Clinical trials and research in stem cell biology continue to uncover new applications for these biological assets in treating diseases and disorders, including cancer, diabetes, and immune rejection. Healthcare providers and individuals increasingly recognize the value of stem cell banking as a form of biological insurance, safeguarding against potential health issues and the aging population's increasing need for chronic disease management. Peripheral blood and adult tissues are also being explored for their stem cell potential. Thus, these factors will drive the demand for stem-cell banking, thereby driving the growth of the global market during the forecast period.
High operating costs associated with storing and processing stem cells is a challenge that affects market growth. The stem cell banking market encompasses the storage and processing of various types of stem cells, including human embryonic cells, induced pluripotent stem cells (IPS cells), and somatic stem cells, for use in regenerative medicine. The high operational costs, particularly in the case of private cord blood banks, are a significant challenge for market growth.
Further, regenerative medicine, a key area of medicine, utilizes these to treat various diseases and disorders, including leukemia, cardiovascular conditions, and chronic diseases. Cryogenically freezing stem cells is a common method for long-term storage to prevent immune rejection. Stem cell research continues to advance, with clinical trials underway for cancer, diabetes, and other conditions. Healthcare providers and individuals seeking personalized medicine may invest in stem cell banking as a form of biological insurance.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Cordlife Group Ltd.: The company offers products which allows a parent to preserve their child's stem-cells present in the umbilical cord blood and used in treating various life-threatening disorders.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
The market is experiencing significant growth due to the increasing demand for regenerative medicine and cell therapy treatments. The Stem Cell Banking sector plays a crucial role in this market, providing essential services for the collection, processing, and storage of stem cells. The use of advanced technologies, such as Cryopreservation and Bioreactors, enables Stem Cell Banks to maintain the viability and potency of stem cells for extended periods. The market is segmented based on the type of stem cells, including Embryonic Stem Cells, Adult Stem Cells, and Induced Pluripotent Stem Cells.
Moreover, the market is driven by factors such as the increasing prevalence of chronic diseases, rising healthcare expenditures, and government initiatives to promote stem cell research. The market is also witnessing collaborations and partnerships between key players, academic institutions, and research organizations to develop new technologies and expand their offerings. The market is expected to grow at a robust pace in the coming years, with major players such as Cord Blood Registry, WiStem, and CBR International, leading the way. The market is also witnessing the entry of new players, fueled by the growing demand for personalized medicine and the potential for significant returns on investment. In summary, the market is a dynamic and growing sector, driven by advancements in technology, increasing demand for regenerative medicine, and government initiatives. The market is expected to continue its growth trajectory in the coming years, with significant opportunities for both established players and new entrants.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
156 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 11.65% |
|
Market growth 2024-2028 |
USD 8.23 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
9.95 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
AMS Biotechnology Europe Ltd., CellSave Arabia FZ LLC, Cordlife Group Ltd., CordVida, Cryo Cell International Inc., Cryo Stemcell, Cryoviva Biotech Pvt. Ltd., FUJIFILM Corp., Global Cord Blood Corp., Kids Clinic India Pvt. Ltd., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., New England Cord Blood Bank Inc., PerkinElmer Inc., Plus Therapeutics Inc., ReeLabs Pvt. Ltd., Regenerative Medical Services Pvt. Ltd., Smart Cells International Ltd., StemCyte India Therapeutics Pvt. Ltd., and Vita 34 International AG |
|
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
